GRIP Molecular Technologies is an American diagnostics company based in Saint Paul, Minnesota.
Organization
GRIP Molecular Technologies is a member of the Rapid Response Partnership Vehicle (RRPV) Consortium.[1]
Personnel
| Name | Position | Notes |
|---|---|---|
| Bruce Batten | Founder, President and CSO[2] | Tufts University, Ohio State University Wexner Medical Center, Thermo Electron, CyberOptics, Advantek, Hylas, BoundaryMedical, IMI Health, Dellwood Country Club, CityKid Java, Ausburg University, Etta Healthcare, OvaGene Oncology, TheoremDx, Thaddeus Medical Systems, Bio-Rad Laboratories |
| Edward Gillen | CEO/COO[3] | Becton Dickinson (BD), Medality Medical |
Investors
Investors in GRIP Molecular include:[4]
- EvoNexus
- gBETA
- gBETA Medtech
External links
Corporate registrations
- GRIP Molecular Technologies, Inc. (Minnesota)
- GRIP Molecular Technologies Inc. (Minnesota)
- GRIP MOLECULAR TECHNOLOGIES INC. (New Jersey)
Current Members. Rapid Response Partnership Vehicle (RRPV). Retrieved January 19, 2025, from https://www.rrpv.org/current-members/ ↩︎
Experience | Bruce Batten. LinkedIn. Retrieved November 1, 2023, from https://www.linkedin.com/in/bruce-batten-8bbb342/details/experience/ ↩︎
Team | Transforming Medical Diagnostics. GRIP Molecular. Retrieved November 2, 2023, from http://archive.today/2023.11.02-055039/https://www.gripmolecular.com/team/ ↩︎
GRIP Molecular Technologies - Funding, Financials, Valuation... Crunchbase. Retrieved November 2, 2023, from https://www.crunchbase.com/organization/grip-molecular-technologies/company_financials ↩︎
